Marcaine 0,25 % Adrénaline

Bupivacaine hydrochloride, the active ingredient in Marcaine 0,25 % Adrénaline, is a local anesthetic (amide) presented as a 0.25% solution for injection for epidural and infiltration use. It provides surgical anesthesia, obstetric analgesia, and postoperative pain control.

GNH USA supplies Marcaine 0,25 % Adrénaline as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare facilities worldwide. The company ensures product quality through strict regulatory compliance and cold‑chain logistics where required. Clients benefit from reliable delivery timelines and dedicated technical support.

Marcaine 0,25 % Adrénaline, a bupivacaine‑epinephrine combination, is used for local anesthesia in various surgical and obstetric settings.

- Surgical anesthesia: provides dense, long‑lasting numbness for operative procedures. - Obstetric analgesia: offers effective pain relief during labor and delivery. - Post‑operative pain control: extends analgesia after surgery to reduce the need for systemic opioids.

Marcaine 0,25 % Adrénaline may cause a range of adverse reactions.

Common Side Effects: - Injection site pain or burning sensation. - Transient hypotension or bradycardia. - Nausea or dizziness. - Metallic taste in the mouth.

Serious or Rare Side Effects: - Cardiovascular collapse or severe arrhythmia. - Central nervous system toxicity such as seizures. - Anaphylactic or severe allergic reaction. - Prolonged motor block or nerve injury.

When using Marcaine 0,25 % Adrénaline, consider the following precautions. - Assess patient allergy: verify no known hypersensitivity to bupivacaine or epinephrine. - Monitor cardiovascular status: observe for arrhythmias or blood pressure changes during and after administration. - Use lowest effective dose: limit total dose according to established guidelines. - Avoid in patients with severe cardiac disease: epinephrine may exacerbate underlying conditions. - Store at room temperature: keep in the original container, protect from light and moisture.

Marcaine 0,25 % Adrénaline can interact with other medicines.

Major Interactions (Avoid): - Beta‑blockers: may potentiate epinephrine‑induced hypertension and tachycardia. - Class I antiarrhythmics (e.g., quinidine): increase risk of cardiac toxicity with bupivacaine. - MAO inhibitors: may enhance epinephrine effects, leading to hypertensive crises.

Moderate Interactions (Monitor Closely): - Concurrent local anesthetics: additive neuro‑ and cardiotoxicity. - Calcium channel blockers: may alter cardiovascular response to epinephrine. - NSAIDs: may increase bleeding risk when combined with vasoconstrictive effects.